Among these patients, 62 (50.00%) showed PSMA expression in >50% of the tumor-associated vasculature (score 2), 22 (17.74%) showed PSMA expression in ≤50% of tumor-associated vasculature (score 1), while 40 (32.26%) did not show detectable PSMA expression (score 0) (Table 2). Here, FOLH1 is linked to neoplasm.